FDA 483 - Valneva Scotland Ltd. - March 05, 2024
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
An FDA inspection of Valneva Scotland Ltd. in Livingston, United Kingdom, revealed significant deficiencies in their biologics/vaccine manufacturing operations. Observations included inadequate environmental monitoring in aseptic processing areas, a quality control unit failing to timely close deviations and manage change requests, and deficient procedures for handling product complaints. Additionally, issues were noted with the drug substance sampling strategy for mycobacteria testing and batch record documentation.
ID · 226a95a2-e671-4c11-bd54-7b0bcf0118c5